[Effect of 5,5-diphenylhydantoin and pneumoencephalography on urinary excretion of 5-hydroxyindoloacetic acid, a serotonin metabolite, and serum ceruloplasmin activity in epileptics].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002570:Ceruloplasmin / Q000378:metabolism*; D004827:Epilepsy / Q000188:drug therapy* / Q000201:enzymology; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine*; D008297:Male; D008875:Middle Aged; D010672:Phenytoin / Q000008:administration & dosage / Q000494:pharmacology*; D011011:Pneumoencephalography; D012701:Serotonin / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D013997:Time Factors
D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D010672:Phenytoin; D012964:Sodium; D002570:Ceruloplasmin
Wpływ 5,5-dwufenylohydantoiny i odmy czaszkowej na wydalanie z moczem metabolitu serotoniny kwasu 5-hydroksyindolooctowego i aktywność ceruloplazminy w surowicy krwi u chorych na padaczke.